LEMAITRE VASCULAR INC
LMATOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M | $129.4M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M | $28.8M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M | $21.2M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M | $252.8M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M | $80.2M |
| Equity | $393.5M | $337.3M | $297.9M | $268.2M | $254.2M | $172.6M |
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 |
| Shares out. | 22.6M | 22.3M | 22.1M | 21.9M | 20.5M | 20.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 27.2%
- Net margin
- 23.1%
- Return on equity
- 14.7%
- Return on assets
- 9.4%
- Return on capital (ROCE)
- 11.7%
- Liabilities / assets
- 36.1%
- Debt / equity
- 0.56×
- Book value / share
- $17.44
- Revenue growth (YoY)
- 13.5%
- Net income growth (YoY)
- 31.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 8.18safe
- Accruals / assets
- −3.8%clean
- Beneish M-Score
- -2.61normal
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lemaitre George WPassive (13G)May 14, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Conestoga Capital Advisors, LlcPassive (13G)Jan 9, 2026
- Blackrock, Inc.Passive (13G)Apr 29, 2025
- Copeland Capital Management, LlcPassive (13G)Jan 24, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lemaitre George WOfficer — Chairman and CEO | May 7, 2026 | Sell | 18,600 | $107.64 |
| Kamke Trent GOfficer — Senior V. P., Operations | May 8, 2026 | Sell | 2,928 | $107.00 |
| Ross Bridget ADirector | May 7, 2026 | Option exercise | 3,444 | $48.60 |
| Jasinski Lawrence JDirector | May 7, 2026 | Option exercise | 1,069 | $47.19 |
| Pellegrino Joseph P JrDirector | Apr 22, 2026 | Option exercise | 2,941 | $35.48 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.2M | 3.7 | -0.8% |
| Apr 30, 2026 | 1.2M | 7.5 | -15.3% |
| Apr 15, 2026 | 1.4M | 7.9 | +2.9% |
| Mar 31, 2026 | 1.3M | 4.2 | +5.9% |
| Mar 13, 2026 | 1.3M | 5.8 | +3.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2026
- Director / officer change · Other material eventApr 14, 2026
- Results of operationsFeb 25, 2026
- Results of operationsNov 6, 2025
- Results of operationsAug 5, 2025
- Shareholder voteJun 3, 2025
- Results of operationsMay 1, 2025
- Results of operationsFeb 27, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.